Amorolfineis a morpholine antifungal drug,can inhibit Δ17-sterol reductase and cholesterol Δ-isomerase,

The global Amorolfine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Amorolfine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Amorolfine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Amorolfine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Amorolfine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Shandong Yinfeida Pharmaceutical
Nishchem International
Canagen Pharmaceuticals Inc
Allastir
Sun Pharma
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Purity:≥98%
Purity:≥99%

Segment by Application
Injection Product
Table Product
Others